These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome. Poulos RC; Thoms JA; Shah A; Beck D; Pimanda JE; Wong JW Mol Cancer Res; 2015 Aug; 13(8):1218-26. PubMed ID: 26082173 [TBL] [Abstract][Full Text] [Related]
7. Synonymous mutations that regulate translation speed might play a non-negligible role in liver cancer development. Li Q; Li J; Yu CP; Chang S; Xie LL; Wang S BMC Cancer; 2021 Apr; 21(1):388. PubMed ID: 33836673 [TBL] [Abstract][Full Text] [Related]
8. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival. Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432 [TBL] [Abstract][Full Text] [Related]
9. The search for cis-regulatory driver mutations in cancer genomes. Poulos RC; Sloane MA; Hesson LB; Wong JW Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674 [TBL] [Abstract][Full Text] [Related]
10. Analysis of SDHD promoter mutations in various types of melanoma. Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518 [TBL] [Abstract][Full Text] [Related]
11. Synonymous mutations frequently act as driver mutations in human cancers. Supek F; Miñana B; Valcárcel J; Gabaldón T; Lehner B Cell; 2014 Mar; 156(6):1324-1335. PubMed ID: 24630730 [TBL] [Abstract][Full Text] [Related]
12. De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia. Takata A; Ionita-Laza I; Gogos JA; Xu B; Karayiorgou M Neuron; 2016 Mar; 89(5):940-7. PubMed ID: 26938441 [TBL] [Abstract][Full Text] [Related]
13. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models. Svetlichnyy D; Imrichova H; Fiers M; Kalender Atak Z; Aerts S PLoS Comput Biol; 2015 Nov; 11(11):e1004590. PubMed ID: 26562774 [TBL] [Abstract][Full Text] [Related]
14. Nonsynonymous, synonymous and nonsense mutations in human cancer-related genes undergo stronger purifying selections than expectation. Chu D; Wei L BMC Cancer; 2019 Apr; 19(1):359. PubMed ID: 30991970 [TBL] [Abstract][Full Text] [Related]
15. Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma. Capasso M; Lasorsa VA; Cimmino F; Avitabile M; Cantalupo S; Montella A; De Angelis B; Morini M; de Torres C; Castellano A; Locatelli F; Iolascon A Cancer Res; 2020 Feb; 80(3):382-393. PubMed ID: 31784426 [TBL] [Abstract][Full Text] [Related]
17. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma. Wan Q; Sang X; Jin L; Wang Z Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099 [TBL] [Abstract][Full Text] [Related]
18. Depletion of somatic mutations in splicing-associated sequences in cancer genomes. Hurst LD; Batada NN Genome Biol; 2017 Nov; 18(1):213. PubMed ID: 29115978 [TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis. Wang X; Chai Z; Li Y; Long F; Hao Y; Pan G; Liu M; Li B Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32316408 [TBL] [Abstract][Full Text] [Related]
20. Adjusting for background mutation frequency biases improves the identification of cancer driver genes. Evans P; Avey S; Kong Y; Krauthammer M IEEE Trans Nanobioscience; 2013 Sep; 12(3):150-7. PubMed ID: 23694700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]